Long-term survival after significant treatment reduction in a patient with CBF-AML

Pediatric Blood and Cancer

Volumn 56, Issue 2, 2011, Pages 325-326

  Driessen, E M C ^a   Van Der Velden, V H J ^b   Catsman Berrevoets, C E ^a   Van Den Heuvel Eibrink, M M ^a   Beishuizen, A ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORE BINDING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; CANCER PATIENT; CANCER SURVIVAL; CASE REPORT; CBFB MYH11 FUSION GENE; FUSION GENE; HUMAN; LETTER; MALE; MINIMAL RESIDUAL DISEASE; PANCYTOPENIA; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CORE BINDING FACTOR BETA SUBUNIT; CORE BINDING FACTORS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MYOSIN HEAVY CHAINS;

EID: 78650104961     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22854     Document Type: Letter

References (8)

1. Gibson BE, Wheatley K, Hann IM, et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005; 19: 2130-2138.
2. Bernbeck B, Janssen G, Winterhalter S, et al. Long time survival after reduced chemotherapy in a 15-year-old patient with AML and Candida krusei sepsis and eye involvement. Klin Padiatr 2009; 221: 384-385.
3. Balgobind BV, Raimondi SC, Harbott J, et al. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: Results of an international retrospective study. Blood 2009; 114: 2489-2496.
4. Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-A Europe Against Cancer program. Leukemia 2003; 17: 2318-2357.
5. Beillard E, Pallisgaard N, van der Velden VH, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-A Europe Against Cancer program. Leukemia 2003; 17: 2474-2486.
6. Mori H, Colman SM, Xiao Z, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002; 99: 8242-8247.
7. McHale CM, Wiemels JL, Zhang L, et al. Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16). Blood 2003; 101: 4640-4641.
8. McHale CM, Smith MT. Prenatal origin of chromosomal translocations in acute childhood leukemia: Implications and future directions. Am J Hematol 2004; 75: 254-257.